Name | Value |
---|---|
Revenues | 1,817.9M |
Cost of Revenue | 1,197.1M |
Gross Profit | 620.8M |
Operating Expense | 368.4M |
Operating I/L | 252.4M |
Other Income/Expense | -232.5M |
Interest Income | 14.1M |
Pretax | 19.9M |
Income Tax Expense | 42.2M |
Net Income/Loss | 14.8M |
Grifols, S.A. is a global leader in the procurement, manufacture, and sale of therapeutic products, specializing in hemoderivatives. The company operates through divisions such as Bioscience, Hospital, Diagnostic, and Bio Supplies. Its Bioscience division focuses on plasma-derived medicines for chronic and rare diseases, while the Hospital division offers non-biological pharmaceutical products and medical supplies. Grifols' Diagnostic division provides a range of diagnostic products for healthcare professionals, and the Bio Supplies division offers biological materials for research and clinical trials. The company serves public and private customers, healthcare providers, and national health systems, generating revenue through the sale of its therapeutic and diagnostic products.